Macromolecular prodrugs of 5-fluorouracil. 2: Enzymatic degradation
- 31 March 1996
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 39 (1), 79-92
- https://doi.org/10.1016/0168-3659(95)00141-7
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Hybridoma cells producing antibodies to cathepsin L have greatly reduced potential for tumour growthZeitschrift für Krebsforschung und Klinische Onkologie, 1994
- Membrane proteases in focusNature, 1994
- Expression and activity of MMPS and their regulators in ovarian cancerInternational Journal of Cancer, 1994
- Secretion of extracellular matrix‐degrading proteinases is increased in epithelial ovarian carcinomaInternational Journal of Cancer, 1994
- Targetable photoactivalable drugs. 3. In vitro efficacy of polymer bound chlorin e6 toward human hepatocarcinoma cell line (PLC/PRF/5) targeted with galactosamine and to mouse splenocytes targeted with anti-Thy 1.2 antibodiesJournal of Controlled Release, 1993
- Macromolecular prodrugs for use in targeted cancer chemotherapy: melphalan covalently coupled to N- (2-hydroxypropyl) methacrylamide copolymersJournal of Controlled Release, 1991
- Soluble Synthetic Polymers for Targeting and Controlled Release of Anticancer Agents, Particularly Anthracycline AntibioticsJournal of Bioactive and Compatible Polymers, 1988
- The synthesis and characterization of polypeptide-adriamycin conjugates and its complexes with adriamycin. Part IJournal of Controlled Release, 1985
- Controlled Release of Drug Model from N-(2-Hydroxypropyl)-methacrylamide CopolymersAnnals of the New York Academy of Sciences, 1985
- Potential and limitations of drug targeting: An overviewBiomaterials, 1985